FDA starts regulating compounding pharmacies

December 2, 2013 by Steven Reinberg, Healthday Reporter
FDA starts regulating compounding pharmacies
New powers designed to make specialty drugs safer for patients.

(HealthDay)—The U.S. Food and Drug Administration on Monday began the process of regulating compounding pharmacies, which create new drug combinations or alter drugs to suit individual patient needs.

Under the Drug Quality and Security Act, signed into law Nov. 27 by President Barack Obama, these pharmacies are being encouraged to register with the FDA. The agency will then classify them as outsourcing pharmacies, enabling them to sell bulk drugs to hospitals and other health-care facilities.

The law was prompted by the deaths last year of 64 people who received fungus-contaminated steroid medications that were given in injections to treat back and joint pain. An additional 750 people in 20 states were sickened by the contaminated . The medication was made by the now-shuttered New England Compounding Center, in Framingham, Mass., according to federal health officials.

"The part of the law related to compounding is a step forward by creating a new pathway in which compounders register with FDA as an outsourcing facility," FDA commissioner Dr. Margaret Hamburg said during a Monday afternoon press briefing.

If a compounding pharmacy registers with the agency, hospitals and other health-care providers will be able to buy products compounded by companies that are subject to FDA oversight, she said.

The oversight includes inspections and adherence to "good manufacturing practices," Hamburg said. To get compounding pharmacies to register, the FDA will encourage hospitals and other health-care providers to buy their compounded products only from FDA-registered companies, she added.

"This will be a critical step they can take to protect the health and safety of their patients," Hamburg said.

For compounders that don't register, the new law removes the uncertainty of FDA's authority to regulate them. This will allow the agency to treat them as any other drug maker, subject to the same scrutiny and drug approvals, she said.

"This uncertainty had presented a challenge for FDA's efforts to oversee compounding pharmacies over the past decade," Hamburg said.

One of the loopholes in the new law: Since pharmacy registration is voluntary, unregistered compounding companies that ship products will only be caught if a problem like contamination arises and is reported.

"We will need to work closely with the states," Hamburg said. "They will have to provide us with ongoing information about the facilities they are overseeing."

The FDA doesn't know just how many compounding pharmacies exist in the United States. Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said there may be as many as 1,000 such businesses.

"While the new law doesn't provide the FDA with all the additional authority it sought, these provisions are definitely progress," Woodcock said at the news conference. "The FDA is committed and stands ready to implement this new law immediately."

In addition to revised regulations for compounding pharmacies, the new also authorizes the FDA to develop a national track-and-trace system. This system should reduce chances for contamination, adulteration or counterfeiting of drugs, Hamburg said.

Explore further: Bulk mixers of prescribed drugs get more scrutiny

More information: For more on compounding pharmacies, visit the U.S. Food and Drug Administration.

Related Stories

Bulk mixers of prescribed drugs get more scrutiny

November 18, 2013
Congress has taken a half step toward increasing federal oversight of so-called compounding pharmacies that custom mix medications in bulk, a year after a meningitis outbreak from contaminated pain injections killed at least ...

FDA chief renews push for specialty pharmacy rules

December 19, 2012
(AP)—The head of the Food and Drug Administration renewed her push for new rules to help police pharmacies like the one that triggered a deadly meningitis outbreak, even as members of Congress expressed little interest ...

Consumer watchdog asks FDA to revisit compounders

November 29, 2012
(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded ...

FDA chief seeks new powers to police pharmacies

November 14, 2012
(AP)—The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak.

Infections from tainted steroids ranged in severity: update

October 23, 2013
(HealthDay)—The tainted steroid injections that caused a deadly meningitis outbreak last year seem to have triggered a broad range of symptoms in patients, according to a new study by the U.S. Centers for Disease Control ...

Compounded medication to prevent preterm birth not a safety risk, pitt study confirms

November 5, 2013
(Medical Xpress)—A new study published online today in the American Journal of Obstetrics and Gynecology by researchers from the University of Pittsburgh School of Medicine and the University of Pittsburgh School of Pharmacy ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.